Mar 13, 2023 9:00am EDT ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual Meeting
Mar 13, 2023 7:00am EDT ProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023
Mar 08, 2023 5:06pm EST ProMIS Neurosciences Announces Full Year 2022 Financial Results and Recent Highlights
Mar 08, 2023 7:00am EST Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference
Nov 14, 2022 7:00am EST ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights
Sep 13, 2022 7:00am EDT ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer
Aug 15, 2022 5:00pm EDT ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Aug 02, 2022 7:00am EDT ProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conference
Jul 27, 2022 7:00am EDT ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference